These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Caffeine as a model drug of dependence: recent developments in understanding caffeine withdrawal, the caffeine dependence syndrome, and caffeine negative reinforcement. Griffiths RR; Chausmer AL Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Nov; 20(5):223-31. PubMed ID: 11326548 [TBL] [Abstract][Full Text] [Related]
29. Reinforcing and subjective effects of several anorectics in normal human volunteers. Chait LD; Uhlenhuth EH; Johanson CE J Pharmacol Exp Ther; 1987 Sep; 242(3):777-83. PubMed ID: 3656112 [TBL] [Abstract][Full Text] [Related]
30. Analysis of the reinforcing and subjective effects of different doses of nitrous oxide using a free-choice procedure. Walker DJ; Zacny JP Drug Alcohol Depend; 2002 Mar; 66(1):93-103. PubMed ID: 11850141 [TBL] [Abstract][Full Text] [Related]
31. Caffeine improves anticipatory processes in task switching. Tieges Z; Snel J; Kok A; Wijnen JG; Lorist MM; Richard Ridderinkhof K Biol Psychol; 2006 Aug; 73(2):101-13. PubMed ID: 16549227 [TBL] [Abstract][Full Text] [Related]
32. Effects of caffeine in chewing gum on mood and attention. Smith A Hum Psychopharmacol; 2009 Apr; 24(3):239-47. PubMed ID: 19330801 [TBL] [Abstract][Full Text] [Related]
33. Individual differences in responses to ethanol and d-amphetamine: a within-subject study. Holdstock L; de Wit H Alcohol Clin Exp Res; 2001 Apr; 25(4):540-8. PubMed ID: 11329494 [TBL] [Abstract][Full Text] [Related]
34. Comparison of diazepam and oxazepam: preference, liking and extent of abuse. Griffiths RR; McLeod DR; Bigelow GE; Liebson IA; Roache JD; Nowowieski P J Pharmacol Exp Ther; 1984 May; 229(2):501-8. PubMed ID: 6716272 [TBL] [Abstract][Full Text] [Related]
35. Ibuprofen plus caffeine in the treatment of tension-type headache. Diamond S; Balm TK; Freitag FG Clin Pharmacol Ther; 2000 Sep; 68(3):312-9. PubMed ID: 11014413 [TBL] [Abstract][Full Text] [Related]
39. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928 [TBL] [Abstract][Full Text] [Related]
40. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years. Kisicki JC; Fiske K; Lyne A Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]